Yale Medicine’s Maternal-Fetal Medicine (MFM) Section offers the Prenatal Diagnostic Program to provide expert genetic screening, testing and counseling for parents. Our tests and services include first-trimester screening, chorionic villus sampling (CVS), amniocentesis, fetal blood sampling (FBS) and many others. Our program also provides counseling and support networks to help parents adjust to and prepare for their child's special needs and to promote informed planning and decision-making.

In addition, our MFM Section is at the cutting edge of clinical management and research in high-risk obstetrics. We are not only leaders in our field, we are also pioneers. Yale Medicine’s Obstetrics, Gynecology & Reproductive Sciences Department is credited with the following medical innovations:

  • Inventing the first fetal echocardiography
  • Pioneering the first obstetrical ultrasound
  • Developing the first fetal blood sampling (FBS) and first fetal transfusion
  • Offering the first chorionic villus sampling (CVS) in New England
  • Developing the first comprehensive First-Trimester Risk Assessment program in New England
  • Co-authoring the first U.S. study for first-trimester risk assessment
  • Inventing fetal monitoring and many prenatal diagnostic and treatment techniques

In addition to pioneering the development of CVS and FBS, we have the most experienced team for these procedures in New England. In addition, we provide fetal echocardiography by the most experienced MFM specialists in the northeastern United States.